FDA Grants Breakthrough Therapy Designation for Rare Genetic Disorder Treatment

WHY IT MATTERS

Breakthrough designation accelerates review and may bring this therapy to patients faster.

The FDA has granted breakthrough therapy designation to a new gene therapy targeting a rare autosomal recessive metabolic disorder.